• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Genet Genomics . Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis

tetano

Editor, Senior Moderator
J Genet Genomics


. 2024 Mar 4:S1673-8527(24)00036-5.
doi: 10.1016/j.jgg.2024.02.007. Online ahead of print. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis

Han Du[SUP] 1 [/SUP], Zhongtao Du[SUP] 2 [/SUP], Liang Wang[SUP] 3 [/SUP], Hong Wang[SUP] 2 [/SUP], Mingjun Jia[SUP] 4 [/SUP], Chunge Zhang[SUP] 5 [/SUP], Yun Liu[SUP] 4 [/SUP], Cheng Zhang[SUP] 1 [/SUP], Ya Zhang[SUP] 3 [/SUP], Ruifeng Zhang[SUP] 3 [/SUP], Shuang Zhang[SUP] 3 [/SUP], Ning Zhang[SUP] 3 [/SUP], Zhenghai Ma[SUP] 6 [/SUP], Chen Chen[SUP] 7 [/SUP], Wenjun Liu[SUP] 4 [/SUP], Hui Zeng[SUP] 8 [/SUP], George F Gao[SUP] 9 [/SUP], Xiaotong Hou[SUP] 10 [/SUP], Yuhai Bi[SUP] 11 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection often leads to pulmonary complications. Cardiovascular sequelae, including myocarditis and heart failure, have also been reported. Here, the study presents two fulminant myocarditis cases infected by SARS-CoV-2 exhibiting remarkable elevation of cardiac biomarkers without significant pulmonary injury, as determined by imaging examinations. Immunohistochemical staining reveals viral antigen within cardiomyocytes, indicating that SARS-CoV-2 could directly infect myocardium. The full viral genomes from respiratory, anal, and myocardial specimens are obtained via next-generation sequencing. Phylogenetic analyses of the whole genome and spike gene indicate that viruses in the myocardium/pericardial effusion and anal swabs are closely related and cluster together yet diverge from those in the respiratory samples. In addition, unique mutations are found in the anal/myocardial strains compared to the respiratory strains, suggesting tissue-specific virus mutation and adaptation. These findings indicate genetically distinct SARS-CoV-2 variants have infiltrated and disseminated within myocardial tissues, independent of pulmonary injury, and point to different infection routes between the myocardium and respiratory tract, with myocardial infections potentially arising from intestinal infection. These findings highlight the potential for systemic SARS-CoV-2 infection and the importance of a thorough multi-organ assessment in patients for a comprehensive understanding of the pathogenesis of COVID-19.

Keywords: COVID-19; SARS-CoV-2; fulminant myocarditis; infection; myocardium.

 
Back
Top Bottom